Dr. Vaibhav V. Shah, MD

Dr. Shah practices at Knight Neurology in Rockledge, Florida.

Dr. Shah's NPI, 1154508083, was assigned on January 22, 2008. Dr. Shah graduated from University of Miami, Miller School of Medicine in 2006. Dr. Shah holds Florida license ME107707.

Dr. Shah's primary practice is Knight Neurology, at 211 Coral Sands Dr, Rockledge, FL 32955 in Brevard County. The practice phone is (321) 345-6331.

Dr. Shah's primary practice is Knight Neurology in Rockledge, Florida. Dr. Shah is also affiliated with Holmes Regional Medical Center. The medical group on file is Knight Neurology. Dmand AI also links Dr. Shah to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shah practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shah's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Shah is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Shah's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Shah treats.

CMS data shows 12,298 Medicare services from Dr. Shah across 10 procedure codes in 2024, for 423 Medicare patients. Medicare paid $179,299 for them. Every service was in an office.

CMS counts 423 Medicare patients who saw Dr. Shah in 2024. The largest group is 75 to 84, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shah's median patient age at 72, with 60% women.

In 2024, Dr. Shah wrote 1,634 Medicare Part D claims for 306 patients. 92% of them were for generic drugs. CMS names the drug for 1,411 of them, across 34 drugs with 11 or more claims each, at $608,952 in total drug cost. In 2023, CMS named 1,663 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Shah for performance year 2024, reported as part of a group. Dr. Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Shah, published from 2023 to 2024. 2023 was the busiest year, with 2. Dr. Shah's most frequent co-authors are Mahboob Alam, MD, M. Chadi Alraies, MD and Islam Youssef Ahmed Elgendy, MD.

CMS Open Payments shows 29 general payments to Dr. Shah from 9 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 78% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $18,404.

Dmand AI lists 1 award for Dr. Shah, most recently CMS Stage 1 EHR in 2013. Dr. Shah serves on Stroke Committee - Wuesthoff.

Dr. Shah graduated from University of Miami, Miller School of Medicine in 2006. Dr. Shah is a member of AAN.

Dr. Shah is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.